Future work will need to assess the ability of ART to reverse this immune dysregulation and explore the role of adjunctive immune checkpoint inhibitors to restore mucosal CD8 T cell function and improve immune protection against respiratory infections in HIV. This evidence concerns the gene CD8A and respiratory tract infectious disorder.